See more : Vaxxinity, Inc. (VAXX) Income Statement Analysis – Financial Results
Complete financial analysis of Omega Healthcare Investors, Inc. (OHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Omega Healthcare Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- E.I.D.- Parry (India) Limited (EIDPARRY.BO) Income Statement Analysis – Financial Results
- Unibel S.A. (UNBL.PA) Income Statement Analysis – Financial Results
- Poniard Pharmaceuticals, Inc. (PARD) Income Statement Analysis – Financial Results
- Mednow Inc. (MNOW.V) Income Statement Analysis – Financial Results
- Ceres Global Ag Corp. (CRP.TO) Income Statement Analysis – Financial Results
Omega Healthcare Investors, Inc. (OHI)
About Omega Healthcare Investors, Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 949.74M | 878.24M | 1.06B | 892.38M | 928.83M | 881.68M | 908.39M | 900.83M | 743.62M | 504.79M | 418.71M | 350.46M | 292.20M | 258.32M | 197.44M | 193.76M | 159.56M | 135.69M | 105.81M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Cost of Revenue | 106.97M | 16.97M | 13.72M | 13.76M | 16.14M | 29.84M | 99.07M | 58.73M | 17.68M | 3.66M | 415.00K | 272.00K | 653.00K | 8.00M | 159.00K | 5.58M | 1.42M | 0.00 | 5.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 842.77M | 861.28M | 1.05B | 878.62M | 912.69M | 851.84M | 809.32M | 842.10M | 725.94M | 501.13M | 418.30M | 350.19M | 291.55M | 250.32M | 197.28M | 188.18M | 158.14M | 135.69M | 100.36M | 90.45M | 86.27M | 137.11M | 257.62M | 275.79M | 122.38M | 108.74M | 90.82M | 73.13M | 61.40M | 37.80M | 20.80M | 5.90M |
| Gross Profit Ratio | 88.74% | 98.07% | 98.71% | 98.46% | 98.26% | 96.62% | 89.09% | 93.48% | 97.62% | 99.27% | 99.90% | 99.92% | 99.78% | 96.90% | 99.92% | 97.12% | 99.11% | 100.00% | 94.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.49 | 0.39 | 0.18 | 0.37 | 0.34 | 0.12 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 15.05M | 11.74M | 11.70M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00M | 20.63M | -2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 81.50M | 67.93M | 63.17M | 58.44M | 56.66M | 63.51M | 47.68M | 45.87M | 38.57M | 25.89M | 21.59M | 21.33M | 19.43M | 23.05M | 32.37M | 9.60M | 11.09M | 13.74M | 8.59M | 6.21M | 5.94M | 6.29M | 10.38M | 6.43M | 6.12M | 5.37M | 4.64M | 4.01M | 3.60M | 2.70M | 1.80M | 500.00K |
| Other Expenses | 0.00 | 401.07M | 419.75M | 367.92M | 301.68M | 287.97M | 10.41M | 286.49M | 276.10M | 129.93M | 131.03M | 113.89M | 106.78M | 84.62M | 47.46M | 71.74M | -398.00K | 32.91M | 25.31M | 24.14M | 0.00 | 0.00 | 229.33M | 296.50M | 24.21M | 21.54M | 16.91M | 13.69M | -16.60M | -9.40M | -4.60M | -1.20M |
| Operating Expenses | 81.50M | 469.00M | 482.92M | 426.36M | 358.34M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.21M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Cost & Expenses | 188.47M | 485.97M | 496.64M | 440.13M | 374.49M | 351.48M | 349.85M | 322.77M | 257.14M | 151.87M | 152.38M | 134.31M | 126.86M | 107.68M | 79.83M | 89.02M | 48.53M | 46.65M | 40.95M | 30.61M | 33.50M | 127.87M | 239.72M | 302.93M | 30.33M | 26.91M | 21.55M | 17.70M | -13.00M | -6.70M | -2.80M | -700.00K |
| Interest Income | 0.00 | 123.92M | 234.60M | 223.39M | 856.00K | 313.00K | 267.00K | 173.00K | 285.00K | 44.00K | 41.00K | 29.00K | 40.00K | 105.00K | 21.00K | 240.00K | 257.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 235.53M | 233.24M | 234.60M | 224.35M | 208.72M | 201.42M | 220.24M | 175.56M | 183.21M | 126.87M | 92.05M | 106.10M | 86.90M | 90.60M | 39.08M | 37.75M | 44.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 319.68M | 485.97M | 496.64M | 648.89M | 374.49M | 351.48M | 349.85M | 322.77M | 210.70M | 123.26M | 128.65M | 112.98M | 100.34M | 84.62M | 44.69M | 39.89M | 36.06M | 32.26M | 27.40M | 23.40M | 20.99M | 21.27M | 22.07M | 23.27M | 24.21M | 21.54M | 16.91M | 13.69M | 13.00M | 6.70M | 3.00M | 800.00K |
| EBITDA | 810.84M | 722.69M | 906.89M | 782.18M | 856.74M | 811.49M | 846.12M | 845.12M | 697.18M | 468.57M | 394.33M | 327.95M | 238.13M | 144.67M | 121.66M | 110.47M | 147.74M | 121.17M | 101.35M | 110.38M | 79.80M | 265.63M | 491.37M | -13.86M | 116.26M | 103.37M | 86.18M | 69.12M | 87.40M | 51.20M | 26.60M | 7.40M |
| EBITDA Ratio | 85.38% | 82.29% | 85.33% | 87.65% | 92.25% | 92.07% | 94.32% | 93.83% | 93.79% | 94.34% | 94.34% | 93.92% | 99.78% | 91.74% | 82.21% | 80.76% | 91.93% | 82.09% | 91.95% | 117.95% | 92.50% | 19.70% | 15.78% | -5.03% | 95.00% | 95.07% | 94.90% | 94.52% | 142.35% | 135.45% | 127.88% | 125.42% |
| Operating Income | 761.27M | 390.28M | 564.88M | 452.26M | 551.75M | 497.59M | 261.26M | 509.75M | 411.27M | 345.31M | 265.68M | 214.97M | 137.80M | 148.94M | 115.89M | 104.74M | 111.03M | 89.04M | 66.46M | 60.10M | 46.06M | 10.19M | 17.22M | -17.15M | 92.04M | 81.83M | 69.27M | 55.43M | 74.40M | 44.50M | 23.60M | 6.60M |
| Operating Income Ratio | 80.16% | 44.44% | 53.15% | 50.68% | 59.40% | 56.44% | 28.76% | 56.59% | 55.31% | 68.41% | 63.45% | 61.34% | 47.16% | 57.66% | 58.69% | 54.05% | 69.58% | 65.62% | 62.81% | 66.44% | 53.40% | 7.43% | 6.69% | -6.22% | 75.21% | 75.26% | 76.28% | 75.79% | 121.17% | 117.72% | 113.46% | 111.86% |
| Total Other Income/Expenses | -505.64M | -318.76M | -525.18M | -585.36M | -207.90M | -201.08M | -209.25M | -175.62M | -176.74M | -123.96M | -93.16M | -94.27M | -85.19M | -90.50M | -33.77M | -27.12M | -43.44M | -30.66M | -26.72M | -43.36M | -6.04M | 3.49M | -677.00K | 9.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 255.63M | 436.14M | 416.08M | 162.33M | 343.84M | 296.51M | 105.92M | 384.33M | 234.53M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 77.62M | 67.59M | 58.39M | 36.69M | 16.74M | 40.02M | 13.68M | 16.55M | -7.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 26.92% | 49.66% | 39.15% | 18.19% | 37.02% | 33.63% | 11.66% | 42.66% | 31.54% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.06% | 42.36% | 43.03% | 34.67% | 18.51% | 46.39% | 9.98% | 6.42% | -2.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 6.26M | 4.56M | 3.84M | 4.93M | 2.84M | 3.01M | 3.25M | 1.41M | 1.21M | 126.87M | 92.05M | 106.10M | 112.74M | -4.00K | 753.00K | -72.00K | -7.00K | 2.35M | 28.18M | 43.10M | 29.74M | 23.89M | 34.56M | 22.42M | 72.37M | 5.62M | 24.42M | 20.84M | 51.40M | 26.70M | 12.00M | 2.20M |
| Net Income | 242.18M | 426.93M | 416.74M | 159.33M | 341.12M | 281.58M | 100.42M | 366.42M | 224.52M | 221.35M | 172.52M | 120.70M | 52.61M | 58.44M | 82.11M | 78.14M | 69.37M | 55.70M | 36.69M | 16.74M | 23.03M | -14.65M | -16.66M | -49.56M | 19.67M | 76.21M | 44.85M | 34.59M | 23.00M | 17.80M | 11.60M | 4.40M |
| Net Income Ratio | 25.50% | 48.61% | 39.21% | 17.85% | 36.73% | 31.94% | 11.05% | 40.68% | 30.19% | 43.85% | 41.20% | 34.44% | 18.00% | 22.62% | 41.59% | 40.33% | 43.48% | 41.05% | 34.67% | 18.51% | 26.70% | -10.68% | -6.47% | -17.97% | 16.07% | 70.08% | 49.38% | 47.30% | 37.46% | 47.09% | 55.77% | 74.58% |
| EPS | 1.04 | 1.81 | 1.76 | 0.70 | 1.60 | 1.41 | 0.51 | 1.91 | 1.30 | 1.75 | 1.47 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| EPS Diluted | 1.00 | 1.75 | 1.71 | 0.68 | 1.54 | 1.34 | 0.51 | 1.90 | 1.29 | 1.74 | 1.46 | 1.12 | 0.46 | 0.52 | 0.87 | 0.94 | 0.90 | 0.78 | 0.49 | -0.81 | 0.09 | -0.42 | -0.83 | -2.22 | 0.51 | 3.39 | 2.16 | 2.01 | 1.43 | 1.70 | 1.78 | 0.68 |
| Weighted Avg Shares Out | 240.49M | 236.26M | 236.93M | 227.74M | 213.40M | 200.28M | 197.74M | 191.78M | 172.24M | 126.55M | 117.26M | 107.59M | 102.12M | 94.06M | 83.56M | 75.13M | 65.86M | 58.65M | 51.74M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
| Weighted Avg Shares Out (Dil) | 250.45M | 244.29M | 244.34M | 235.10M | 222.13M | 209.71M | 206.79M | 201.64M | 180.51M | 127.29M | 118.10M | 108.01M | 102.18M | 94.24M | 83.65M | 75.21M | 65.89M | 58.75M | 52.06M | 45.33M | 39.07M | 34.89M | 20.03M | 22.31M | 19.69M | 20.00M | 19.17M | 17.20M | 16.08M | 8.79M | 6.52M | 6.47M |
I'm Locking Up To 9% Yield In This Target Rich Environment
The current market has many appealing high-yield choices, despite the S&P 500 trading near all-time highs.
Why I'm Buying These 2 REITs Hand Over Fist
Real estate sector has underperformed this year, but I believe it is due to an erosion of perception, not value. Top real estate stocks have generally reported strong earnings results, beating estimates and raising guidance. Here are two top REITs...
4 Healthcare REITs On The Crest Of The Silver Tsunami
The aging Baby Boomer generation presents a significant opportunity for investors due to its large size and increasing healthcare needs. Businesses are targeting the Baby Boomer market to capitalize on their specific characteristics and preferences. Real estate investment trusts that...
Omega Healthcare Investors (OHI) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago...
Omega Healthcare Investors, Inc. (OHI) Q1 2024 Earnings Call Transcript
Omega Healthcare Investors, Inc. (NYSE:OHI ) Q1 2024 Earnings Conference Call May 3, 2024 10:00 AM ET Company Participants Michele Reber - Investor Relations Taylor Pickett - Chief Executive Officer Dan Booth - Chief Operating Officer Bob Stephenson - Chief...
Omega Healthcare Investors (OHI) Beats Q1 FFO and Revenue Estimates
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.68 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to FFO of $0.66 per share a year ago.
Omega Reports First Quarter 2024 Results and Recent Developments
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2024. FIRST QUARTER 2024 AND RECENT HIGHLIGHTS Net income for the quarter of $69 million, or $0.27...
Omega Healthcare Investors: Dividend Safety Has Become A Concern (Rating Downgrade)
I am downgrading my rating on Omega Healthcare Investors (OHI) stock to SELL. The dividend yield is no longer attractive compared to historical averages and risk-free interest rates. Most importantly, the dividend safety has become a concern due to payout...
Omega Announces Quarterly Dividend and Schedules First Quarter Earnings Release Date and Conference Call
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced the quarterly dividend on its common stock and its first quarter earnings release date. Quarterly Dividend Declaration Omega today announced that the Company's Board of Directors declared a cash dividend...
ESRT vs. OHI: Which Stock Is the Better Value Option?
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Empire State Realty Trust (ESRT) and Omega Healthcare Investors (OHI). But which of these two stocks is more attractive to value investors?
Source: https://incomestatements.info
Category: Stock Reports